Investigación > Epidemiología, Enfermedades infecciosas y Salud pública

Farmacoepidemiología y farmacodinámica

Nombre de publicacions
218
Cercador de publicacions
  • García Del Blanco B; Otaegui I; Rodríguez-Palomares JF; Bayés-Genis A; Fernández-Nofrerías E; Vilalta Del Olmo V; Carrillo X; Ibáñez B; Worner F; Casanova J; Pueo E; González-Juanatey JR; López-Pais J; Bardají A; Bonet G; Fuertes M; Rodríguez-Sinovas A; Ruiz-Meana M; Inserte J; Barba I; Gómez-Talavera S; Martí G; Serra B; Bellera N; Ojeda-Ramos M; Cuellar H; Valente F; Carmona MÁ; Miró-Casas E; Marsal JR; Sambola A; Lidón RM; Bañeras J; Elízaga J; Padilla F; Barrabés JA; Hausenloy DJ; Ferreira-González I; García-Dorado D

    Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI).

    BASIC RESEARCH IN CARDIOLOGY 116 4-4. .

    [doi:10.1007/s00395-021-00842-2]

  • Rubio-Salvador, AR; Escudero-Vilaplana, V; Rodriguez, JAM; Mangues-Bafalluy, I; Bernardez, B; Collado, CG; Collado-Borrell, R; Fernandez, MDA; Lopez-Muniz, JIC; Cortes, MY; Barrera, MG; Calleja-Hernandez, MA

    Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 18 -. .

    [doi:10.3390/ijerph18020394]

  • Aluja A; Malas O; Urieta P; Worner F; Balada F

    Biological correlates of the Toronto Alexithymia Scale (TAS-20) in cardiovascular disease and healthy community subjects.

    PHYSIOLOGY & BEHAVIOR 227 113151-113151. .

    [doi:10.1016/j.physbeh.2020.113151]

  • Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A

    An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.

    GYNECOLOGIC ONCOLOGY 159 721-731. .

    [doi:10.1016/j.ygyno.2020.09.013]

  • Chicote J; Yuste VJ; Boix J; Ribas J

    Cell Death Triggered by the Autophagy Inhibitory Drug 3-Methyladenine in Growing Conditions Proceeds With DNA Damage.

    Frontiers in Pharmacology 11 580343-580343. .

    [doi:10.3389/fphar.2020.580343]

  • Pont C; Ascaso FJ; Grzybowski A; Huerva V

    Corneal endothelial cell density during diabetes mellitus and ocular diabetes complications treatment.

    JOURNAL FRANCAIS D OPHTALMOLOGIE 43 794-798. .

    [doi:10.1016/j.jfo.2019.12.003]

  • Librada-Flores S; Nabal-Vicuña M; Forero-Vega D; Muñoz-Mayorga I; Guerra-Martín MD

    Implementation Models of Compassionate Communities and Compassionate Cities at the End of Life: A Systematic Review.

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 17 -. .

    [doi:10.3390/ijerph17176271]

  • González-Haba-Peña E; Garrido-Siles M; Martínez-Bautista MJ; Burgos-San José A; Aldaz-Pastor A; Mangues-Bafalluy I

    Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients.

    FARMACIA HOSPITALARIA 44 192-197. .

    [doi:10.7399/fh.11402]

  • Fernández-Vázquez D; Ferrero-Gregori A; Álvarez-García J; Gómez-Otero I; Vázquez R; Delgado Jiménez J; worner diz f; Bardají A; García-Pavía P; Bayés-Genís A; González-Juanatey JR; Cinca J; Pascual Figal DA

    Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction.

    Revista Española De Cardiología (english Ed.) 73 561-568. .

    [doi:10.1016/j.rec.2019.09.030]

  • Jáuregui-Abularach M; Merchán-Ortega G; Menéndez-Ramírez D; Martín-Sánchez G; Sánchez-Millán P; Worner-Diz, F; Campos-Garc?a, B

    Radiofrequency ablation of superoparaseptal-parahisian accessory pathways from the sinuses of Valsalva region: a three case report.

    Journal Of Interventional Cardiac Electrophysiology 58 119-121. .

    [doi:10.1007/s10840-020-00717-x]

  • Porcel, JM; Ferreiro, L; Rumi, L; Espino-Paisan, E; Civit, C; Pardina, M; Schoenenberger-Arnaiz, JA; Valdes, L; Bielsa, S

    Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial

    Pleura and Peritoneum 5 20190027-20190027. .

    [doi:10.1515/pp-2019-0027]

  • Schoenenberger-Arnaiz, JA; Ahmad-Diaz, F; Miralbes-Torner, M; Aragones-Eroles, A; Cano-Marron, M; Palomar-Martinez, M

    Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 27 30-35. .

    [doi:10.1136/ejhpharm-2018-001713]